Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_assertion type Assertion NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_head.
- NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_assertion wasGeneratedBy ECO_0000203 NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_provenance.
- NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_assertion wasDerivedFrom befree-20140225 NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_provenance.
- NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_assertion SIO_000772 22926105 NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_provenance.
- NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_assertion evidence source_evidence_literature NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_provenance.
- NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_assertion description "[Although point-mutation technology of TAA peptide may increase the binding capability to MHC molecules, some previous studies have revealed that part of the variant peptides results in lymphocyte not to effectively cross-recognize and kill the target tumor expressed wild-type TAA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350302.RAowxw9u8yHLxCHMiFN76d5BHkoA1S_twjNrgamaUNdPE130_provenance.